Form 4 for CNMD CONMED Corp
Accepted 2025-11-03 00:00:00 ET · period of report 2025-10-31 · accession 0000816956-25-000044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-03 | 2025-10-31 | CNMD | Garner Todd W | EVP, CFO | M - OptEx | $0.00 | +7,500 | 7,500 | New | $0 |
| D | 2025-11-03 | 2025-10-31 | CNMD | Garner Todd W | EVP, CFO | F - Tax | $44.00 | -2,164 | 5,336 | -29% | -$95.2K |
| D | 2025-11-03 | 2025-10-31 | CNMD | Garner Todd W | EVP, CFO | M - OptEx | $0.00 | -7,500 | 15.2K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-31 | M | A | 7,500 | $0.00 | 7,500 | D | — | — | |
| 2 | Common | Common Stock | 2025-10-31 | F | D | 2,164 | $44.00 | 5,336 | D | — | — | |
| 3 | Derivative | RSUs (Restricted Stock Units) | 2025-10-31 | M | D | 7,500 | $0.00 | 15,227 | D | — · — to — | 7,500 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company"). (F2) The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 33% vesting after year 1 and 67% vesting after year 2. |